BrightSpring Health Services (NASDAQ:BTSG) Issues Earnings Results, Misses Expectations By $0.02 EPS

BrightSpring Health Services (NASDAQ:BTSG) issued its earnings results on Thursday. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.02), Zacks reports. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%.

BrightSpring Health Services Trading Down 4.1 %

NASDAQ BTSG traded down $0.76 during trading on Thursday, hitting $17.63. The company had a trading volume of 1,046,738 shares, compared to its average volume of 1,493,670. The company’s fifty day moving average is $20.04 and its 200-day moving average is $17.45. BrightSpring Health Services has a one year low of $7.85 and a one year high of $24.82. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The company has a market cap of $3.07 billion and a price-to-earnings ratio of -67.80.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Bank of America upped their target price on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Morgan Stanley increased their price objective on BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Wells Fargo & Company boosted their target price on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. CJS Securities began coverage on shares of BrightSpring Health Services in a research note on Thursday, December 12th. They set an “outperform” rating and a $27.00 price target on the stock. Finally, UBS Group upped their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.80.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.